Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heinzelmann

Showing results (591-600 of 663) with videos related to

Pageof 67
Sort By:
Elife|October 7, 2020
Collagen-rich omentum is a premetastatic niche for integrin α2-mediated peritoneal metastasisYen-Lin Huang, Ching-Yeu Liang, Danilo Ritz, et al.
JCO Precision Oncology|July 2, 2025
Geneva Homologous Recombination Deficiency Test Is Predictive of Survival Benefit From Olaparib and Bevacizumab Maintenance in Ovarian CancerYann Christinat, Intidhar Labidi-Galy, Liza Ho, et al.
Oncoimmunology|April 9, 2016
Expression of inhibitory receptors on intratumoral T cells modulates the activity of a T cell-bispecific antibody targeting folate receptorJens Schreiner, Daniela S Thommen, Petra Herzig, et al.
NPJ Precision Oncology|February 6, 2026
Ex vivo drug sensitivity testing predicts treatment outcomes in advanced ovarian cancerKathrin B Labrosse, Flavio C Lombardo, Ewelina M Bartoszek, et al.
Cancers|April 12, 2022
Intention to Inform Relatives, Rates of Cascade Testing, and Preference for Patient-Mediated Communication in Families Concerned with Hereditary Breast and Ovarian Cancer and Lynch Syndrome: The Swiss CASCADE CohortMahesh Sarki, Chang Ming, Souria Aissaoui, et al.
JMIR Research Protocols|September 22, 2017
Cancer Predisposition Cascade Screening for Hereditary Breast/Ovarian Cancer and Lynch Syndromes in Switzerland: Study ProtocolMaria C Katapodi, Valeria Viassolo, Maria Caiata-Zufferey, et al.
Cancers|May 27, 2026
Patients' Perception of Follow-Up Care and Personal Health Status of 677 Long-Term Survivors of Gynecological Cancer from the Study "Expression IX-Long-Term Survival with Gynecological Cancer": The International NOGGO, ENGOT and GCIG SurveyHannah Woopen, Tibor Zwimpfer, Luise Brenner, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 10, 2026
Gender and regional equity in the European Society of Gynaecological Oncology: a longitudinal analysis of a professional medical societyTibor A Zwimpfer, Houssein El Hajj, Alina E Sturdza, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 15, 2025
Accelerated vs. conventionally fractionated postoperative radiotherapy of non-small cell lung cancer-final results of the prematurely terminated PORTAF trialRebecca Bütof, Lydia Koi, Steffen Löck, et al.
Nature Genetics|June 2, 2025
Phylogenetic inference reveals clonal heterogeneity in circulating tumor cell clustersDavid Gremmelspacher, Johannes Gawron, Barbara M Szczerba, et al.
Pageof 67

Showing results (591-600 of 663) with videos related to

Sort By:
Pageof 67
Elife|October 7, 2020
Collagen-rich omentum is a premetastatic niche for integrin α2-mediated peritoneal metastasisYen-Lin Huang, Ching-Yeu Liang, Danilo Ritz, et al.
JCO Precision Oncology|July 2, 2025
Geneva Homologous Recombination Deficiency Test Is Predictive of Survival Benefit From Olaparib and Bevacizumab Maintenance in Ovarian CancerYann Christinat, Intidhar Labidi-Galy, Liza Ho, et al.
Oncoimmunology|April 9, 2016
Expression of inhibitory receptors on intratumoral T cells modulates the activity of a T cell-bispecific antibody targeting folate receptorJens Schreiner, Daniela S Thommen, Petra Herzig, et al.
NPJ Precision Oncology|February 6, 2026
Ex vivo drug sensitivity testing predicts treatment outcomes in advanced ovarian cancerKathrin B Labrosse, Flavio C Lombardo, Ewelina M Bartoszek, et al.
Cancers|April 12, 2022
Intention to Inform Relatives, Rates of Cascade Testing, and Preference for Patient-Mediated Communication in Families Concerned with Hereditary Breast and Ovarian Cancer and Lynch Syndrome: The Swiss CASCADE CohortMahesh Sarki, Chang Ming, Souria Aissaoui, et al.
JMIR Research Protocols|September 22, 2017
Cancer Predisposition Cascade Screening for Hereditary Breast/Ovarian Cancer and Lynch Syndromes in Switzerland: Study ProtocolMaria C Katapodi, Valeria Viassolo, Maria Caiata-Zufferey, et al.
Cancers|May 27, 2026
Patients' Perception of Follow-Up Care and Personal Health Status of 677 Long-Term Survivors of Gynecological Cancer from the Study "Expression IX-Long-Term Survival with Gynecological Cancer": The International NOGGO, ENGOT and GCIG SurveyHannah Woopen, Tibor Zwimpfer, Luise Brenner, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 10, 2026
Gender and regional equity in the European Society of Gynaecological Oncology: a longitudinal analysis of a professional medical societyTibor A Zwimpfer, Houssein El Hajj, Alina E Sturdza, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 15, 2025
Accelerated vs. conventionally fractionated postoperative radiotherapy of non-small cell lung cancer-final results of the prematurely terminated PORTAF trialRebecca Bütof, Lydia Koi, Steffen Löck, et al.
Nature Genetics|June 2, 2025
Phylogenetic inference reveals clonal heterogeneity in circulating tumor cell clustersDavid Gremmelspacher, Johannes Gawron, Barbara M Szczerba, et al.
Pageof 67